Press releases
Read more:
Categories
2021
2021-09-17 11:15
Nanologica Closes NIC-001
Nanologica AB has decided to close the project with the drug candidate NIC-001 for the treatment of gastroparesis before the planned clinical study begins...
2021-08-19 08:20
Nanologica Recruits Chief Scientific Officer
Nanologica has recruited Gary Pitcairn as Chief Scientific Officer as part of the strategy to increase the focus on inhalation and respiratory diseases...
Nanologica has completed the first study within the tox program for the inhalation platform NLAB Spiro®. The program now continues with further studies...
2021-06-30 19:55
Exercise of Rights in Nanologica’s Stock Option Program
In Nanologica's stock option program 2018/21 exercise of rights in Nanologica’s stock option program has increased the number of shares in the...
2021-06-16 08:31
Nanologica’s patent granted in Australia
The Australian Patent Office has granted Nanologica’s patent titled ”A process for manufacturing porous silica particles loaded with at least...
2021-06-08 14:38
Nanologica's CEO sells shares and buys options
CEO Andreas Bhagwani has privately and through his company Vega Bianca AB divested 323,000 shares in Nanologica AB for private economic reasons. At the...
2021-06-02 08:44
Nanologica Recruits VP Drug Development
To accelerate the development of the NLAB Spiro® inhalation platform, Ulf Ericsson has been recruited as VP Drug Development. The position includes...
2021-05-17 07:58
Nanologica’s Patent Application Published
The invention relates to new pharmaceutical compositions, their use as medical treatments and particularly to their administration to the lung to treat...
2021-05-05 14:11
Nanologica Publishes Annual Report for 2020
Nanologica hereby announces that the annual report for 2020 has been published. The report is available on the company’s website www.nanologica.com...
2021-04-23 08:18
Nanologica Interim Report Jan-Mar 2021
IMPORTANT MILESTONES ACHIEVED IN BOTH BUSINESS AREAS Successful upscaling of the production of silica to ton scale advances Nanologica’s position...